search
Back to results

Impact of Immunonutrition on the Patients With Cystic Fibrosis

Primary Purpose

Cystic Fibrosis, Malnutrition, Oxidative Stress

Status
Unknown status
Phase
Phase 4
Locations
Czech Republic
Study Type
Interventional
Intervention
Impact-Nutridrink
Nutridrink-Impact
Sponsored by
University Hospital, Motol
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Cystic Fibrosis focused on measuring cystic fibrosis, immunonutrition, oxidative stress

Eligibility Criteria

18 Years - 40 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Cystic fibrosis
  • adult, elder 18 years
  • enteral nutrition at least for the last 12 monthes

Exclusion Criteria:

  • patient waiting for lung transplant
  • patients with another life limiting disease-e.g. cancers

Sites / Locations

  • Faculty hospital MotolRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Impact-Nutridrink

Nutridrink-Impact

Arm Description

The first arm will be given immunonutrition -Impact- for 8 weeks, afterwards the patients will return to their previous nutrition support for another 8 weeks. We expect the improvement of oxidative stress parameters after 8 weeks of immunonutriton and return to baseline values when immunonutrition is stopped

The second group will be given their previous nutrition support (Nutridrink) for 8 weeks, afterwards the patients will be switched to immunonutrition- Impact- for another 8 weeks. In this group of patients we do not expect any change of oxidative stress parameters after the first 8 weeks. The improvement is expected at the end of the second half of study.

Outcomes

Primary Outcome Measures

to evaluate the change of oxidative stress in patients with cystic fibrosis induced by immunonutrition
Oxidative stress and parameters of antioxidant activity will be evaluated when the nutrition support is provided with classic sipping (Nutridrink-Nutricia) or by immunonutrition (Impact-Nestle)

Secondary Outcome Measures

to evaluate the change of inflammatory parameters in patients with cystic fibrosis induced by the application of immunonutrition

Full Information

First Posted
December 16, 2013
Last Updated
January 27, 2014
Sponsor
University Hospital, Motol
search

1. Study Identification

Unique Protocol Identification Number
NCT02048592
Brief Title
Impact of Immunonutrition on the Patients With Cystic Fibrosis
Official Title
Impact of Immunonutrition on the Patients With Cystic Fibrosis
Study Type
Interventional

2. Study Status

Record Verification Date
January 2014
Overall Recruitment Status
Unknown status
Study Start Date
September 2013 (undefined)
Primary Completion Date
September 2014 (Anticipated)
Study Completion Date
December 2014 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital, Motol

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The primary objectives: To evaluate the effect of immunonutrition on the adult patient suffering from cystic fibrosis Safety of immunonutrition The effect of immunonutrition on parameters of oxidative stress The effect of immunonutrition on the inflammatory parameters The effect of immunonutrition on nutrition status Hypothesis The high oxidative stress is present in patients with cystic fibrosis. Immunonutrition has been shown to positively modulate oxidative stress in the different clinical setting however it has not yet been evaluated inpatients with cystic fibrosis who frequently need some support by means of enteral nutrition. We anticipate that the substitution of routine enteral nutrition by immunonutrition will result in improving of oxidative stress parameters. ,
Detailed Description
Method Crossover open study will take 16 weeks. The patients eligible for the study according to inclusion and exclusion criteria are going to be divided into 2 groups after signing the informed consent. In both groups their nutrition status, humoral and cellular immunity, respiratory system function and parameters of oxidative stress will be evaluated before entering the intervention. Afterwards the patients are going to be divided into one group who will receive nutrition support using immunonutrition for the next 8 weeks while the second one will continue with their nutrition support using routine sipping support with no immunonutrition. According to our hypothesis oxidative stress parameters will improve in the group of patients on immunonutrition comparing to the other group. Afterwards the patients will change their nutrition support for another 8 weeks. The patients who took immunonutrition in the first half of study will switch back to routine sipping support and contrary the patients who were in the first part of study on routine sipping will take immunonutrition. After the end of this period of study we expect the return of oxidative stress parameters to the baseline values in the group of patients who took immunonutrition in the first half of study but who were returned to routine nutrition support and contrary the improvement of oxidative stress parameters in the patients who started to take immunonutrition in the second half of study. The total energy support will be identical in both periods for each individual patient. After the first 8 weeks and after the completion of study the same examination are going to be evaluate as it was on the entrance to study. Statistical analysis: means, SD, t-test, chi square test, Mann Whitney test, linear correlation and multilinear analysis

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cystic Fibrosis, Malnutrition, Oxidative Stress
Keywords
cystic fibrosis, immunonutrition, oxidative stress

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 4
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Impact-Nutridrink
Arm Type
Active Comparator
Arm Description
The first arm will be given immunonutrition -Impact- for 8 weeks, afterwards the patients will return to their previous nutrition support for another 8 weeks. We expect the improvement of oxidative stress parameters after 8 weeks of immunonutriton and return to baseline values when immunonutrition is stopped
Arm Title
Nutridrink-Impact
Arm Type
Active Comparator
Arm Description
The second group will be given their previous nutrition support (Nutridrink) for 8 weeks, afterwards the patients will be switched to immunonutrition- Impact- for another 8 weeks. In this group of patients we do not expect any change of oxidative stress parameters after the first 8 weeks. The improvement is expected at the end of the second half of study.
Intervention Type
Dietary Supplement
Intervention Name(s)
Impact-Nutridrink
Other Intervention Name(s)
Impact is brand name of oral nutrition produced by Nestle-Switzerland. It improves immune system, Nutridrink is brand name of oral nutrition produced by company Nutricia (Denmark) with no effect on immune system.
Intervention Description
IMPACT (immunonutrition) will be given in the first 8 weeks. Afterwards the patients will be returned to their previous nutrition support |(Nutridrink) for another 8 weeks.
Intervention Type
Dietary Supplement
Intervention Name(s)
Nutridrink-Impact
Other Intervention Name(s)
Impact- brand name for immunonutrition - company Nestle Switzerland, Nutridrink- nutrition of company Nutriticia (Denmark)- with no immune response
Intervention Description
In this group of patients - the study starts with period of 8 weeks with no change of previous nutrition support (Nutridrink). After 8 weeks the laboratory results will be examined ant the patients will switch to immunonutrition (Impact) for another 8 weeks. After the laboratory examination including oxidative stress parameters will be evaluated.
Primary Outcome Measure Information:
Title
to evaluate the change of oxidative stress in patients with cystic fibrosis induced by immunonutrition
Description
Oxidative stress and parameters of antioxidant activity will be evaluated when the nutrition support is provided with classic sipping (Nutridrink-Nutricia) or by immunonutrition (Impact-Nestle)
Time Frame
16 weeks
Secondary Outcome Measure Information:
Title
to evaluate the change of inflammatory parameters in patients with cystic fibrosis induced by the application of immunonutrition
Time Frame
16 weeks
Other Pre-specified Outcome Measures:
Title
to evaluate the change of nutrition parameters in patients with cysic fibrosis induced by the application of immunonutrition
Time Frame
16 weeks
Title
to evaluate the change of respiratory function in patients with cystic fibrosis induced by immunonutrition
Time Frame
16 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Cystic fibrosis adult, elder 18 years enteral nutrition at least for the last 12 monthes Exclusion Criteria: patient waiting for lung transplant patients with another life limiting disease-e.g. cancers
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ondrej Hloch, MD
Phone
+420224434098
Email
o.hloch@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Jiri Charvat, MD
Phone
+420224434051
Email
jiri.charvat@fnmotol.cz
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ondrej Hloch, MD
Organizational Affiliation
Faculty hospital Motol
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jiri Charvat, MD
Organizational Affiliation
Faculty hospital Motol
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Milan Kvapil, MD
Organizational Affiliation
Faculty hospital Motol
Official's Role
Study Director
Facility Information:
Facility Name
Faculty hospital Motol
City
Prague
ZIP/Postal Code
15006
Country
Czech Republic
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Libor Fila, MD
Phone
+420224436630
Email
libor.fila@fnmotol.cz
First Name & Middle Initial & Last Name & Degree
Ondrej Hloch, MD
First Name & Middle Initial & Last Name & Degree
Libor Fila, MD

12. IPD Sharing Statement

Learn more about this trial

Impact of Immunonutrition on the Patients With Cystic Fibrosis

We'll reach out to this number within 24 hrs